MedPath

BE?WEL (Breast - Evaluation of Weight and Exercise for Lymphoedema): a feasibility study to compare four different weight control and exercise programmes for women with breast cancer related lymphoedema

Not Applicable
Completed
Conditions
ymphoedema, Breast Cancer
Cancer
Malignant neoplasm of breast
Registration Number
ISRCTN86789850
Lead Sponsor
niversity Hospital of South Manchester NHS Foundation Trust (UK)
Brief Summary

2024 Results article in https://doi.org/10.1007/s10549-024-07356-0 (added 20/05/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Women receiving maintenance therapy for breast cancer related arm lymphoedema i.e. compression sleeves + / - manual lymphatic drainage
2. Overweight/obese BMI > 25 Kg /m2
3. Stable lymphoedema over the past 3 months defined as:
3.1. No intensive therapy (i.e. no manual decongestive treatment)
3.2. No recorded 10% change in volume of the affected arm lasting > 7 days (assessed with perometer)
3.3. No lymphoedema related infections (cellulitis) requiring antibiotics
4. Had lymphoedema sleeve reassessed by lymphoedema practitioner within the last 3 months
5. Any age
6. Able to understand written instructions and record diet diaries
7. No chemotherapy in previous 3 months or radiotherapy in the previous 12 months
8. Live within Greater Manchester / Cheshire area to maximise uptake and retention to programme and study
9. Sedentary < 40 minute moderate exercise / week
10. Willing to be randomised to the 4 treatment groups
11. Written informed consent

Exclusion Criteria

1. Metastatic disease or axillary recurrence
2. Physical/psychiatric condition which limits compliance to diet and exercise interventions
3. Eastern Cooperative Oncology Group (ECOG) performance status < 2
4. Already losing weight or following exercise programme
5. Plans for surgery during the study period
6. Pace maker

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath